ProShares, a leading provider of leveraged and inverse ETFs, announced the launch on Friday of the first ETFs with leveraged and inverse exposure to the biotechnology sector. The Ultra Nasdaq Biotechnology (BIB) will seek to provide 200% of the return on the NASDAQ Biotechnology Index for a single day. The UltraShort Nasdaq Biotechnology (BIS) will [...] Related Stories: ProShares Files For More Leveraged ETFs: China, Biotech, Real Estate, Materials ProShares Launches First Inverse China, Real Estate, Materials ETFs ProShares Launches Inverse Treasury ETF